Table 4.
Expression levels of serum miRNAs (mean ± SD), PG (median ± SD) between different gastric disease groups when stratified by H.pylori status
| Variables | CON | AG | GC | P-value | |
|---|---|---|---|---|---|
|
Hp- |
|
|
|
|
|
| miR-20a-5p |
3.83 ± 0.71 |
3.88 ± 0.59 |
3.85 ± 0.70 |
0.926 |
|
| Male |
3.84 ± 0.72 |
3.90 ± 0.59 |
3.89 ± 0.34 |
0.931 |
|
| Female |
3.82 ± 0.71 |
3.86 ± 0.60 |
3.75 ± 0.53 |
0.881 |
|
| let-7a |
|
3.74 ± 0.31 |
3.81 ± 0.31 |
3.76 ± 0.25 |
0.505 |
| Male |
3.73 ± 0.31 |
3.84 ± 0.34 |
3.77 ± 0.25 |
0.36 |
|
| Female |
3.76 ± 0.30 |
3.76 ± 0.28 |
3.74 ± 0.27 |
0.972 |
|
| miR-320a |
|
5.02 ± 0.48 |
4.90 ± 0.45 |
4.91 ± 0.47 |
0.311 |
| Male |
5.03 ± 0.50 |
4.97 ± 0.48 |
4.98 ± 0.44 |
0.813 |
|
| Female |
4.99 ± 0.44 |
4.81 ± 0.41 |
4.74 ± 0.50 |
0.216 |
|
| PGA |
|
134.99 ± 92.27 |
96.78 ± 76.05 |
141.99 ± 125.80 |
0.056 |
| PGC |
|
15.13 ± 13.67 |
10.37 ± 9.02 |
23.15 ± 25.11 |
0.001 |
| PGA/PGC |
|
10.66 ± 4.81 |
11.00 ± 6.04 |
9.17 ± 6.28 |
0.22 |
|
Hp+ |
|
|
|
|
|
| miR-20a-5p |
3.69 ± 0.78 |
3.79 ± 0.79 |
3.81 ± 0.66 |
0.743 |
|
| Male |
3.75 ± 0.86 |
3.90 ± 0.31 |
3.86 ± 0.82 |
0.785 |
|
| Female |
3.62 ± 0.66 |
3.53 ± 0.55 |
3.74 ± 0.43 |
0.542 |
|
| let-7a |
|
3.68 ± 0.38 |
3.74 ± 0.27 |
3.74 ± 0.31 |
0.661 |
| Male |
3.70 ± 0.31 |
3.73 ± 0.30 |
3.77 ± 0.33 |
0.717 |
|
| Female |
3.66 ± 0.48 |
3.75 ± 0.18 |
3.70 ± 0.28 |
0.795 |
|
| miR-320a |
|
4.95 ± 0.44 |
4.98 ± 0.45 |
4.89 ± 0.40 |
0.634 |
| Male |
5.01 ± 0.49 |
5.05 ± 4.59 |
5.05 ± 0.46 |
0.961 |
|
| Female |
4.87 ± 0.36 |
4.81 ± 0.38 |
4.72 ± 0.36 |
0.471 |
|
| PGA |
|
162.15 ± 112.44 |
125.81 ± 92.66 |
114.74 ± 75.23 |
0.058 |
| PGC |
|
24.82 ± 20.80 |
17.86 ± 13.95 |
23.10 ± 20.16 |
0.182 |
| PGA/PGC | 7.91 ± 4.49 | 7.97 ± 3.70 | 6.16 ± 3.57 | 0.06 | |